Marsh & McLennan Companies, Inc. Benefits Administration Committee | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Marsh & McLennan Companies, Inc. Benefits Administration Committee

Sort by

Viewing results 1‒25 of 177

Nomura Holdings Inc
Nomura hires former top UK Treasury official Tom Scholar as European chair
...Some complained privately that the Conservative administration was impugning the impartiality of the state’s most senior officials....
December 1, 2023
Hydrogen power
Energy groups mount campaign against tough US clean hydrogen rules
...said Andy Marsh, chief executive of Plug Power, who signed an industry letter this week urging the Biden administration to take a “pragmatic approach” with the Treasury guidance....
July 30, 2023
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
News in-depthDementia
Alzheimer’s drug Leqembi falls short of blockbuster status in faltering US rollout
...An FDA advisory committee of outside experts will adjudicate on the drug in the coming months....
April 22, 2024
News in-depthTikTok Inc
TikTok fortune of billionaire Republican donor Jeff Yass threatened by Washington
...But new rules unveiled by the Biden administration last year would limit SIG’s ability to invest in Chinese artificial intelligence, semiconductors and quantum computing....
April 24, 2024
The Week Ahead
Round two for US Republican voters
...Key economic and company reports Here is a more complete list of what to expect in terms of company reports and economic data this week....
January 21, 2024
Energy Source
How Biden’s climate law spurred a tax credit revolution Premium content
...McLennan....
January 18, 2024
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Boeing Co
Grounded Boeing planes won’t return to service until they are safe, official says
...The US Federal Aviation Administration grounded 171 Boeing 737 Max 9s on Saturday....
January 10, 2024
Legal services
In-house legal work: best practice case studies
...Marsh McLennan O: 6; L: 7; I: 6; Total: 19 The insurance group’s legal team established a committee, including representatives from the management team, that oversees ESG reporting and the sustainability...
December 6, 2022
News in-depthBig Tech
Big Tech increases funding to US foreign policy think-tanks
...Last month, the American Innovation and Choice Online Act passed through the Senate committee stage, despite a vigorous lobbying effort against it by the companies affected....
February 1, 2022
The Week Ahead
A new era beckons for China
...Key economic and company reports Here is a more complete list of what to expect in terms of company reports and economic data this week....
October 16, 2022
Moral Money
Here’s why S&P dropped Tesla from its flagship ESG index Premium content
...(Patrick Temple-West and Simon Mundy) Smart read Marsh McLennan is arranging insurance for a controversial east African oil pipeline, putting the world’s largest broker at the centre of a project that...
May 20, 2022
Covid-19 vaccines
FDA panel backs Novavax Covid jab with hopes of persuading sceptics
...The panel vote represents an important milestone for Novavax, a Maryland-based biotech company which signed a $1.6bn deal with the US government in 2020 to develop a Covid vaccine....
June 7, 2022
Anjana Ahuja
Hasty approval for Alzheimer’s drug offers a cautionary tale
...Some suggest the medicines should be given earlier, to maximise benefit, even though many people with plaques will never develop Alzheimer’s....
April 17, 2022
News in-depthInsurance
Collapse of Aon-Willis deal validates insurers’ fears about broker power
...and health benefits broking....
August 31, 2021
Biogen Inc
Biogen halves price of Alzheimer’s drug after sales fall short
...Experts have been divided over whether the drug has a significant benefit. The US Food and Drug Administration approved Aduhelm in June, despite a vote against it by its scientific advisers....
December 20, 2021
FT Live
US Decarbonization and Industrial Transition Summit
Securing the resources to build and finance America's clean energy future
Wednesday, 29 MayWashington, D.C., USA
Aon PLC
Aon chief defends logic of failed $30bn Willis tie-up
...The DoJ had offered a starkly different picture, claiming that the big three brokers — Aon, Willis and Marsh McLennan — dominate broking for the largest companies due to their global span and expertise....
August 16, 2021
Coronavirus treatment
Merck’s Covid pill secures narrow backing from US regulatory panel
...Over several hours on Tuesday, the FDA committee’s members debated whether the modest benefits provided by the drug outweighed the potential safety risks....
November 30, 2021
Covid-19 vaccines
FDA approves Moderna and J&J Covid booster shots
...The Biden administration’s rollout of booster doses has been delayed by internal government rows over whether they are really necessary....
October 20, 2021
Covid-19 vaccines
FDA panel votes against Pfizer’s Covid-19 booster jab application
...Pfizer said it would work with the vaccines committee to address its questions and that it continued to believe in the benefits of boosters for a broader population....
September 17, 2021
Covid-19 vaccines
Scientists who quit FDA criticise plan for widespread Covid vaccine boosters
...Even if some gain can ultimately be obtained from boosting, it will not outweigh the benefits of providing initial protection to the unvaccinated.”...
September 13, 2021
ETF HubLatest news on ETFs
ETF industry heavyweights push back on proposed US tax change
...when the Biden administration is looking to fund a massive spending package for social programmes....
September 17, 2021
Covid-19 vaccines
Biden urges Americans to ‘wait their turn’ for booster jabs
...regulators at the US Food and Drug Administration and the Centers for Disease Control and Prevention....
September 24, 2021
News in-depthCovid-19 vaccines
Confusion abounds as US rolls out scaled-back booster campaign
...William Schaffner, infectious diseases professor at Vanderbilt University in Nashville and liaison member of the CDC’s vaccine advisory committee, said the public’s confusion stemmed from the Biden administration...
September 30, 2021
Coronavirus treatment
Merck says Covid antiviral pill halves risk of hospitalisation and death
...The decision to halt the study was taken following a recommendation from an independent committee of scientists monitoring the trial and after consultations with the FDA....
October 1, 2021
Disrupted Times
Pfizer defends vaccine booster programmes Premium content
...Talking to the Financial Times, Philip Dormitzer, Pfizer’s chief scientific officer, dismissed criticism that the company is pushing the widespread administration of Covid-19 booster shots too aggressively...
September 8, 2021

Previous pagePage 1 of 8Next page